Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S17 pseudogene 11 (RPS17P11) is one of many processed pseudogenes derived from the parent gene RPS17, which encodes a component of the 40S ribosomal subunit essential for protein synthesis in human cells[3][4][5]. Pseudogenes like RPS17P11 are DNA sequences that resemble protein-coding genes but do not produce functional proteins, typically due to mutations or lack of regulatory elements. These pseudogenes are widely dispersed throughout the human genome, especially for ribosomal protein genes[3][5][6]. RPS17P11 itself does not encode a functional ribosomal protein, does not participate in ribosome assembly, and has no established biological, pathophysiological, or therapeutic role. If you are seeking information on the functional ribosomal protein S17 (RPS17), which supports production of the ribosomal 40S subunit and whose dysfunction is associated with Diamond-Blackfan anemia, it is a different entity—RPS17, not RPS17P11[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S17 pseudogene 11 (RPS17P11).